Jade Biosciences, Inc. (JBIO NASDAQ) stock market data APIs
$16.1207
-0.27(-1.7%)
as of June 15, 2026
Try our APIs with
free plan!
Jade Biosciences, Inc. Financial Data Overview
Price chart is built with
Anychart
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Prev. Close
16.1207
Open
15.8547
High
16.3104
Low
15.5
52 wk Range
6.67-28
Market Cap
934 M
Shares Outstanding
60 860 K
EPS
-0.57
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Jade Biosciences, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Jade Biosciences, Inc. data using free add-ons & libraries
Get Jade Biosciences, Inc. Fundamental Data
Jade Biosciences, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -113 516 000
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: -0.48
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Jade Biosciences, Inc. News
New
At a glance: stocks gapping down premarket
[Wall Street New York City] aluxum/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-down moves before the bell Thursday. Stock index futures (SPX [https://seekingalpha.com/s...
Jade Biosciences prices $150M public offering of common stock at $15/share
Jade Biosciences (JBIO [https://seekingalpha.com/symbol/JBIO]) has announced the pricing of a public offering [https://seekingalpha.com/pr/20539889-jade-biosciences-announces-pricing-of-public-offerin...
Jade Biosciences Prices $150 Mln Offering Of Shares At $15.00/shr; Stock Down
(RTTNews) - Jade Biosciences, Inc. (JBIO), a clinical-stage biotechnology company, priced a public offering of 10 million shares at $15.00 per share. The gross proceeds to Jade from the offering are e...
Jade Biosciences Announces Pricing of Public Offering of Common Stock
SAN FRANCISCO and VANCOUVER, British Columbia, June 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focus...
Get Jade Biosciences, Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
